Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial.
Inhaled antibiotics control chronic airway infection and maintain respiratory health in cystic fibrosis (CF). Given variation in patient responses to inhaled antibiotics, the ability to identify distinct responder phenotypes would facilitate the delivery of personalized care. Previously, a 10-gene p...
Main Authors: | Silvia M Caceres, Linda A Sanders, Noel M Rysavy, Katie R Poch, Caroline R Jones, Kyle Pickard, Tasha E Fingerlin, Roland A Marcus, Kenneth C Malcolm, Jennifer L Taylor-Cousar, David P Nichols, Jerry A Nick, Matthew Strand, Milene T Saavedra |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0267592 |
Similar Items
-
Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis
by: Kenneth C. Malcolm, et al.
Published: (2022-08-01) -
Deficient Complement Opsonization Impairs Mycobacterium avium Killing by Neutrophils in Cystic Fibrosis
by: Patricia M. Lenhart-Pendergrass, et al.
Published: (2023-02-01) -
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.
by: Green, R, et al.
Published: (2002) -
Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum
by: Shute Janis K, et al.
Published: (2009-07-01) -
Rheological and Low Field NMR Characterisation of Cystic Fibrosis Patient’s Sputum
by: G. Staltari, et al.
Published: (2023-02-01)